Stoneridge (SRI) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
12 Mar, 2026Executive summary
Achieved $861.3 million in 2025 sales, outperforming weighted-average OEM end markets by up to 1.5% despite a 6.7% decline, driven by 69%–70% MirrorEye sales growth to $111 million.
Completed the sale of the Control Devices segment for $59 million in early 2026, focusing on high-growth, high-return businesses and reducing complexity.
Announced $830 million in new business awards, including the largest in company history for MirrorEye and Stoneridge Brazil OEM programs.
Leadership transition: Natalia Noblet promoted to President and CEO effective April 1, 2026, with a focus on sustainable, profitable growth and operational excellence.
Achieved positive free cash flow of $19 million in 2025 through improved inventory management and cost controls.
Financial highlights
Adjusted gross profit for 2025 was $173.6 million (20.2% margin), down from $189.8 million (20.9%) in 2024.
Adjusted EBITDA for 2025 was $25.0 million (2.9% of sales), down from $28.6 million (3.2%) in 2024.
Net loss for 2025 was $102.8 million, or $(3.70) per share, with significant non-recurring charges; adjusted net loss was $31.9 million, or $(1.15) per share.
Adjusted free cash flow for 2025 was $19.0 million, compared to $26.4 million in 2024.
Cash and cash equivalents at year-end 2025 were $66.3 million; net debt was $114.7 million.
Outlook and guidance
2026 revenue guidance: $625 million–$650 million (midpoint $638 million), driven by at least 45% MirrorEye sales growth.
Adjusted EBITDA guidance for 2026: $20 million–$25 million (3.2%–3.8% margin); gross margin guidance: 21.5%–22.0%.
2027 revenue target: at least $715 million; EBITDA target: at least $44 million (6.2% margin).
2030 revenue target: $850 million–$1 billion; EBITDA target: $80 million–$120 million (9.5%–12% margin), representing a 6.8%–10.3% CAGR.
MirrorEye take rates projected at 35%–50% in Europe and 5%–15% in North America for 2026.
Latest events from Stoneridge
- Q2 2024 saw margin gains, EPS growth, and updated guidance as key tech launches accelerated.SRI
Q2 20242 Feb 2026 - Control Devices sold for $59M to focus on advanced electronics and reduce debt.SRI
Status update2 Feb 2026 - MirrorEye and Smart 2 drive growth through innovation, safety, and regulatory compliance.SRI
CL King’s 22nd Annual Best Ideas Conference 202420 Jan 2026 - Q3 sales and earnings declined, but cash flow and MirrorEye adoption showed improvement.SRI
Q3 202417 Jan 2026 - Growth driven by MirrorEye, Smart 2, and operational improvements despite market softness.SRI
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - MirrorEye/Mirai and Smart 2 growth offset market declines, driving margin and cash flow gains.SRI
Q4 202426 Dec 2025 - Margin gains and record product sales drive Q1, with guidance reaffirmed despite net loss.SRI
Q1 202524 Dec 2025 - 2025 proxy covers director elections, auditor ratification, compensation, and new LTIP.SRI
Proxy Filing2 Dec 2025 - Shareholders to vote on a new incentive plan consolidating all future equity awards.SRI
Proxy Filing2 Dec 2025